{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:01Z","timestamp":1786980121116,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00406-025-02188-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:12:20Z","timestamp":1774678340000},"page":"1595-1613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4112-751X","authenticated-orcid":false,"given":"Yves Martins","family":"Varela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagner Deuel","family":"de O. Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Macedo","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor Augusto Trindade","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Queiroz","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00edssa M.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Agr\u00edcola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Santos","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bheatrix","family":"Bienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Falchi-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Cavalcanti-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Palhano-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Fernandes-Osterhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Draulio Barros","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2188_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00943","volume":"10","author":"JJ Fuentes","year":"2020","unstructured":"Fuentes JJ, Fonseca F, Elices M et al (2020) Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials. Front Psychiatry 10:943. https:\/\/doi.org\/10.3389\/fpsyt.2019.00943","journal-title":"Front Psychiatry"},{"key":"2188_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.887255","volume":"13","author":"M Cavarra","year":"2022","unstructured":"Cavarra M, Falzone A, Ramaekers JG, Kuypers KPC, Mento C (2022) Psychedelic-assisted psychotherapy-a systematic review of associated psychological interventions. Front Psychol 13:887255. https:\/\/doi.org\/10.3389\/fpsyg.2022.887255","journal-title":"Front Psychol"},{"issue":"3","key":"2188_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14030248","volume":"14","author":"MR Velit-Salazar","year":"2024","unstructured":"Velit-Salazar MR, Shiroma PR, Cherian E (2024) A systematic review of the neurocognitive effects of psychedelics in healthy populations: implications for depressive disorders and post-traumatic stress disorder. Brain Sci 14(3):248. https:\/\/doi.org\/10.3390\/brainsci14030248","journal-title":"Brain Sci"},{"issue":"1","key":"2188_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/02698811211044688","volume":"36","author":"RF Leger","year":"2022","unstructured":"Leger RF, Unterwald EM (2022) Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: a systematic review and meta-analysis. J Psychopharmacol 36(1):20\u201330. https:\/\/doi.org\/10.1177\/02698811211044688","journal-title":"J Psychopharmacol"},{"issue":"6","key":"2188_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","volume":"23","author":"E Krediet","year":"2020","unstructured":"Krediet E, Bostoen T, Breeksema J et al (2020) Reviewing the potential of psychedelics for the treatment of PTSD. Int J Neuropsychopharmacol 23(6):385\u2013400. https:\/\/doi.org\/10.1093\/ijnp\/pyaa018","journal-title":"Int J Neuropsychopharmacol"},{"key":"2188_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115886","volume":"335","author":"Y Yao","year":"2024","unstructured":"Yao Y, Guo D, Lu TS, Liu FL, Huang SH et al (2024) Efficacy and safety of psychedelics for the treatment of mental disorders: a systematic review and meta-analysis. Psychiatr Res 335:115886. https:\/\/doi.org\/10.1016\/j.psychres.2024.115886","journal-title":"Psychiatr Res"},{"issue":"2","key":"2188_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.psc.2024.02.006","volume":"47","author":"L Leone","year":"2024","unstructured":"Leone L, McSpadden B, DeMarco A, Enten L, Kline R, Fonzo GA (2024) Psychedelics and evidence-based psychotherapy: a systematic review with recommendations for advancing psychedelic therapy research. Psychiatr Clin North Am 47(2):367\u2013398. https:\/\/doi.org\/10.1016\/j.psc.2024.02.006","journal-title":"Psychiatr Clin North Am"},{"issue":"3","key":"2188_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1037\/cns0000237","volume":"7","author":"SW Wheeler","year":"2020","unstructured":"Wheeler SW, Dyer NL (2020) A systematic review of psychedelic-assisted psychotherapy for mental health: an evaluation of the current wave of research and suggestions for the future. Psychol Conscious Theory Res Pract 7(3):279\u2013315. https:\/\/doi.org\/10.1037\/cns0000237","journal-title":"Psychol Conscious Theory Res Pract"},{"key":"2188_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20503245251380511","volume":"11","author":"DJ Nutt","year":"2025","unstructured":"Nutt DJ, Erritzoe D, Schlag A et al (2025) A lexicon for psychedelic research and treatment. Drug Science, Policy and Law 11:1\u20138. https:\/\/doi.org\/10.1177\/20503245251380511","journal-title":"Drug Science, Policy and Law"},{"key":"2188_CR10","unstructured":"Grof S, Halifax J (1978) The human encounter with death: a study of the therapeutic effects of psychedelic substances in treating existential crises. E. P. Dutton, New York."},{"issue":"4","key":"2188_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/0022167817715960","volume":"57","author":"CS Grob","year":"2017","unstructured":"Grob CS, Bossis A (2017) Humanistic psychology, psychedelics, and the transpersonal vision. J Humanist Psychol 57(4):315\u2013318. https:\/\/doi.org\/10.1177\/0022167817715960","journal-title":"J Humanist Psychol"},{"issue":"4","key":"2188_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1176\/appi.psychotherapy.20200055","volume":"74","author":"DM Horton","year":"2021","unstructured":"Horton DM, Morrison B, Schmidt J (2021) Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy. Am J Psychother 74(4):140\u2013149. https:\/\/doi.org\/10.1176\/appi.psychotherapy.20200055","journal-title":"Am J Psychother"},{"issue":"3","key":"2188_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.focus.20220088","volume":"21","author":"BR Lewis","year":"2023","unstructured":"Lewis BR, Byrne K (2023) A review of MDMA-assisted therapy for posttraumatic stress disorder. Focus (American Psychiatric Publishing) 21(3):247\u2013256. https:\/\/doi.org\/10.1176\/appi.focus.20220088","journal-title":"Focus (American Psychiatric Publishing)"},{"issue":"6","key":"2188_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A et al (2021) MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med 27(6):1025\u20131033. https:\/\/doi.org\/10.1038\/s41591-021-01336-3","journal-title":"Nat Med"},{"issue":"2","key":"2188_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/02791072.2019.1606472","volume":"51","author":"RE Doblin","year":"2019","unstructured":"Doblin RE, Christiansen M, Jerome L, Burge B (2019) The past and future of psychedelic science: an introduction to this issue. J Psychoact Drugs 51(2):93\u201397. https:\/\/doi.org\/10.1080\/02791072.2019.1606472","journal-title":"J Psychoact Drugs"},{"key":"2188_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/JPR.S360733","volume":"15","author":"SJ Drozdz","year":"2022","unstructured":"Drozdz SJ, Goel A, McGarr MW et al (2022) Ketamine assisted psychotherapy: a systematic narrative review of the literature. J Pain Res 15:1691\u20131706. https:\/\/doi.org\/10.2147\/JPR.S360733","journal-title":"J Pain Res"},{"issue":"3","key":"2188_CR17","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2023.53","volume":"9","author":"BM Kew","year":"2023","unstructured":"Kew BM, Porter RJ, Douglas KM, Glue P, Mentzel CL, Beaglehole B (2023) Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review. BJPsych Open 9(3):e79. https:\/\/doi.org\/10.1192\/bjo.2023.53","journal-title":"BJPsych Open"},{"key":"2188_CR18","volume-title":"Retrain your brain: cognitive behavioral therapy in 7 weeks","author":"SJ Gillihan","year":"2016","unstructured":"Gillihan SJ (2016) Retrain your brain: cognitive behavioral therapy in 7 weeks. Althea Press, Berkeley"},{"key":"2188_CR19","doi-asserted-by":"publisher","DOI":"10.1037\/11433-000","volume-title":"Culturally responsive cognitive-behavioral therapy: assessment","author":"PA Hays","year":"2006","unstructured":"Hays PA, Iwamasa GY (2006) Culturally responsive cognitive-behavioral therapy: assessment. American Psychological Association, Practice, And Supervision. https:\/\/doi.org\/10.1037\/11433-000"},{"issue":"2","key":"2188_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000467984","volume":"8","author":"S Grof","year":"1973","unstructured":"Grof S, Goodman LE, Richards WA et al (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8(2):129\u2013144. https:\/\/doi.org\/10.1159\/000467984","journal-title":"Int Pharmacopsychiatry"},{"issue":"2","key":"2188_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/02791072.1968.10524522","volume":"4","author":"J Sherwood","year":"2012","unstructured":"Sherwood J, Stolaroff M, Harman W (2012) The psychedelic experience\u2014a new concept in psychotherapy. J Psychoactive Drugs 4(2):69\u201380. https:\/\/doi.org\/10.1080\/02791072.1968.10524522","journal-title":"J Psychoactive Drugs"},{"key":"2188_CR22","unstructured":"AT, Emery G (1979). Cognitive therapy of depression. Guilford Press."},{"key":"2188_CR23","unstructured":"Beck JS (2021). Cognitive behavior therapy: basics and beyond (3rd ed.). Guilford Press."},{"issue":"5","key":"2188_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10608-012-9476-1","volume":"36","author":"SG Hofmann","year":"2012","unstructured":"Hofmann SG, Asnaani A, Vonk IJJ et al (2012) The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res 36(5):427\u2013440. https:\/\/doi.org\/10.1007\/s10608-012-9476-1","journal-title":"Cogn Ther Res"},{"key":"2188_CR25","doi-asserted-by":"publisher","unstructured":"American Psychological Association, Presidential Task Force on Evidence-Based Practice (2006) Evidence-based practice in psychology. Am Psychol. 61(4): 271\u2013285. https:\/\/doi.org\/10.1037\/0003-066X.61.4.271","DOI":"10.1037\/0003-066X.61.4.271"},{"issue":"12","key":"2188_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.2017.13737","volume":"318","author":"F Leichsenring","year":"2017","unstructured":"Leichsenring F, Steinert C (2017) Is cognitive behavioral therapy the gold standard for psychotherapy? The need for plurality in treatment and research. JAMA 318(12):1323\u20131324. https:\/\/doi.org\/10.1001\/jama.2017.13737","journal-title":"JAMA"},{"issue":"11","key":"2188_CR27","doi-asserted-by":"publisher","DOI":"10.2196\/14754","volume":"21","author":"MB Schure","year":"2019","unstructured":"Schure MB, Lindow JC, Greist JH et al (2019) Use of a fully automated internet-based cognitive behavior therapy intervention in a community population of adults with depression symptoms: randomized controlled trial. J Med Internet Res 21(11):e14754. https:\/\/doi.org\/10.2196\/14754","journal-title":"J Med Internet Res"},{"issue":"4","key":"2188_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10567-007-0028-2","volume":"10","author":"BC Chu","year":"2007","unstructured":"Chu BC, Harrison TL (2007) Disorder-specific effects of CBT for anxious and depressed youth: a meta-analysis of candidate mediators of change. Clin Child Fam Psychol Rev 10(4):352\u2013372. https:\/\/doi.org\/10.1007\/s10567-007-0028-2","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2188_CR29","first-page":"45","volume":"13","author":"H Flynn","year":"2014","unstructured":"Flynn H, Warren R (2014) Using CBT effectively for treating depression and anxiety. Curr Psychiatr. 13:45\u201347+50","journal-title":"Curr Psychiatr."},{"key":"2188_CR30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20200045","volume":"86","author":"JE Curtiss","year":"2023","unstructured":"Curtiss JE, Levine DS, Ander I et al (2023) Cognitive-behavioral treatments for anxiety and stress-related disorders. J Anxiety Disord 86:102551. https:\/\/doi.org\/10.1176\/appi.focus.20200045","journal-title":"J Anxiety Disord"},{"key":"2188_CR31","volume-title":"Cognitive-behavioral treatment of borderline personality disorder","author":"MM Linehan","year":"1993","unstructured":"Linehan MM (1993) Cognitive-behavioral treatment of borderline personality disorder. Guilford Press"},{"issue":"2","key":"2188_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/105504999305686","volume":"55","author":"MM Linehan","year":"1999","unstructured":"Linehan MM, Schmidt H, Dimeff LA et al (1999) Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. J Clin Psychol 55(2):177\u2013188. https:\/\/doi.org\/10.1080\/105504999305686","journal-title":"J Clin Psychol"},{"issue":"1","key":"2188_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40473-017-0103-z","volume":"4","author":"LW Choi-Kain","year":"2017","unstructured":"Choi-Kain LW, Finch EF, Masland SR, Jenkins JA, Unruh BT (2017) What works in the treatment of borderline personality disorder. Curr Behav Neurosci Rep. 4(1):21\u201330. https:\/\/doi.org\/10.1007\/s40473-017-0103-z","journal-title":"Curr Behav Neurosci Rep."},{"key":"2188_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpra.2009.06.001","author":"GH Eifert","year":"2009","unstructured":"Eifert GH, Forsyth JP, Arch J, Espejo E, Keller M, Langer D (2009) Acceptance and commitment therapy for anxiety disorders: three case studies exemplifying a unified treatment protocol. Cogn Behav Pract. https:\/\/doi.org\/10.1016\/j.cbpra.2009.06.001","journal-title":"Cogn Behav Pract"},{"issue":"5","key":"2188_CR35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1037\/a0028310","volume":"80","author":"J Arch","year":"2012","unstructured":"Arch J, Eifert GH, Davies C et al (2012) Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. J Consult Clin Psychol 80(5):750\u2013765. https:\/\/doi.org\/10.1037\/a0028310","journal-title":"J Consult Clin Psychol"},{"key":"2188_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1474088","volume":"151","author":"Z Walsh","year":"2023","unstructured":"Walsh Z, Thiessen MS (2023) Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy. Behav Res Ther 151:104089. https:\/\/doi.org\/10.1080\/09540261.2018.1474088","journal-title":"Behav Res Ther"},{"issue":"7","key":"2188_CR37","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3389\/fpsyg.2022.873279","volume":"240","author":"DB Yaden","year":"2023","unstructured":"Yaden DB, Earp D, Graziosi M et al (2023) Psychedelics and psychotherapy: cognitive-behavioral approaches as default. Psychopharmacology 240(7):2029\u20132042. https:\/\/doi.org\/10.3389\/fpsyg.2022.873279","journal-title":"Psychopharmacology"},{"issue":"11","key":"2188_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP et al (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol 28(11):983\u2013992. https:\/\/doi.org\/10.1177\/0269881114548296","journal-title":"J Psychopharmacol"},{"key":"2188_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J et al (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. https:\/\/doi.org\/10.1016\/S2215-0366(16)30065-7","journal-title":"Lancet Psychiatry"},{"key":"2188_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcbs.2019.11.0","volume":"15","author":"J Sloshower","year":"2020","unstructured":"Sloshower J, Guss J, Krause R et al (2020) Psilocybin-assisted therapy of major depressive disorder using acceptance and commitment therapy as a therapeutic frame. J Context Behav Sci 15:12\u201319. https:\/\/doi.org\/10.1016\/j.jcbs.2019.11.0","journal-title":"J Context Behav Sci"},{"key":"2188_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2188_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000517074","volume":"86","author":"ST Wilkinson","year":"2017","unstructured":"Wilkinson ST, Wright D, Fasula MK et al (2017) Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression. Psychother Psychosom 86:162\u2013167. https:\/\/doi.org\/10.1159\/000517074","journal-title":"Psychother Psychosom"},{"key":"2188_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/20008198.2020.1840123","author":"CM Monson","year":"2020","unstructured":"Monson CM, Wagner AC, Mithoefer AT et al (2020) MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial. Eur J Psychotraumatol. https:\/\/doi.org\/10.1080\/20008198.2020.1840123","journal-title":"Eur J Psychotraumatol"},{"issue":"5","key":"2188_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000517074","volume":"90","author":"ST Wilkinson","year":"2021","unstructured":"Wilkinson ST, Rhee TG, Joormann J et al (2021) Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial. Psychother Psychosom 90(5):318\u2013327. https:\/\/doi.org\/10.1159\/000517074","journal-title":"Psychother Psychosom"},{"issue":"6","key":"2188_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/02698811231154852","volume":"37","author":"J Sloshower","year":"2023","unstructured":"Sloshower J, Skosnik PD, Safi-Aghdam H et al (2023) Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial. J Psychopharmacol 37(6):698\u2013706. https:\/\/doi.org\/10.1177\/02698811231154852","journal-title":"J Psychopharmacol"},{"issue":"7","key":"2188_CR46","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbapap.2018.03.006","volume":"186","author":"BK Pradhan","year":"2018","unstructured":"Pradhan BK, Mitreva L, Moaddel R et al (2018) D-serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R, S)-ketamine infusion and TIMBER psychotherapy: a pilot study. Biochim et Biophys Acta (BBA) Prot Proteom. 186(7):831\u2013839. https:\/\/doi.org\/10.1016\/j.bbapap.2018.03.006","journal-title":"Biochim et Biophys Acta (BBA) Prot Proteom."},{"issue":"6","key":"2188_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.euroneuro.2017.10.013","volume":"28","author":"CI Rodriguez","year":"2016","unstructured":"Rodriguez CI, Wheaton M, Zwerling J et al (2016) Can exposure-based cbt extend IV ketamine\u2019s effects in OCD? An open-label trial. Eur Neuropsychopharmacol 28(6):770\u2013771. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.10.013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"2188_CR48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","volume":"79","author":"MP Bogenschutz","year":"2022","unstructured":"Bogenschutz MP, Ross S, Bhatt S et al (2022) Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiat 79(10):953\u2013962. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2096","journal-title":"JAMA Psychiat"},{"issue":"3","key":"2188_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/2542-3932.211589","volume":"2","author":"BK Pradhan","year":"2017","unstructured":"Pradhan BK, Wainer IW, Moaddel R et al (2017) Trauma interventions using mindfulness-based extinction and reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on post-traumatic stress disorder and comorbid depression: a pilot randomized, placebo-controlled, crossover clinical trial. Asia Pac J Clin Trials Nerv Syst Dis 2(3):80\u201390. https:\/\/doi.org\/10.4103\/2542-3932.211589","journal-title":"Asia Pac J Clin Trials Nerv Syst Dis"},{"key":"2188_CR50","first-page":"59","volume-title":"The mindfulness-informed educator: building acceptance and psychological flexibility in higher education","author":"S Georgescu","year":"2016","unstructured":"Georgescu S, Brock M (2016) A contextual cognitive-behavioral therapy approach to clinical professional training: Inside the classroom. In: Block-Lerner J, Cardaciotto L (eds) The mindfulness-informed educator: building acceptance and psychological flexibility in higher education. Routledge\/Taylor & Francis Group, pp 59\u201377"},{"key":"2188_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","volume":"11","author":"M Wolff","year":"2020","unstructured":"Wolff M, Evens R, Mertens LJ et al (2020) Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance. Front Psych 11:5. https:\/\/doi.org\/10.3389\/fpsyt.2020.00005","journal-title":"Front Psych"},{"key":"2188_CR52","volume-title":"Acceptance and commitment therapy: the process and practice of mindful change","author":"SC Hayes","year":"2016","unstructured":"Hayes SC, Strosahl KD, Wilson KG (2016) Acceptance and commitment therapy: the process and practice of mindful change, 2nd edn. The Guilford Press, New York","edition":"2"},{"key":"2188_CR53","volume-title":"Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse","author":"ZV Segal","year":"2018","unstructured":"Segal ZV, Williams JMG, Teasdale JD (2018) Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse, 2nd edn. The Guilford Press, New York","edition":"2"},{"key":"2188_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jcbs.2019.10.003","volume":"14","author":"JB Luoma","year":"2019","unstructured":"Luoma JB, Sabucedo P, Eriksson J et al (2019) Toward a contextual psychedelic assisted therapy: contextual behavioral science and the third wave of psychedelic research. J Contextual Behav Sci 14:136\u2013145. https:\/\/doi.org\/10.1016\/j.jcbs.2019.10.003","journal-title":"J Contextual Behav Sci"},{"key":"2188_CR55","unstructured":"Mithoefer MC (2015) A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (Version 7). MAPS Public Benefit Corporation. https:\/\/maps.org\/research-archive\/mdma\/MDMA-Assisted-Psychotherapy-Treatment-Manual-Version7-19Aug15-FINAL.pdf. Accessed 28 January 2025"},{"key":"2188_CR56","unstructured":"Mustafa RA, McQueen B, Nikitin D et al (2024) MDMA-Assisted Psychotherapy for Post-Traumatic Stress Disorder: Effectiveness and Value; Final Evidence Report. Institute for Clinical and Economic Review. https:\/\/icer.org\/assessment\/ptsd-2024\/#overview. Accessed 28 January 2025"},{"issue":"1","key":"2188_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0004867419883341","volume":"54","author":"K Witt","year":"2020","unstructured":"Witt K, Potts J, Hubers A et al (2020) Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials. Aust N Z J Psychiatry 54(1):29\u201345","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"2188_CR58","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.biopsych.2021.03.014","volume":"1","author":"H Wu","year":"2021","unstructured":"Wu H, Savalia NK, Kwan AC (2021) Ketamine for a boost of neural plasticity: how, but also when? Biol Psychiatry 1(11):1030\u20131032. https:\/\/doi.org\/10.1016\/j.biopsych.2021.03.014","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2188_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","volume":"52","author":"JB Luoma","year":"2020","unstructured":"Luoma JB, Chwyl C, Bathje GJ et al (2020) A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. J Psychoactive Drugs 52(4):289\u2013299. https:\/\/doi.org\/10.1080\/02791072.2020.1769878","journal-title":"J Psychoactive Drugs"},{"key":"2188_CR60","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s12671-023-02206-4","volume":"14","author":"R Chambers","year":"2023","unstructured":"Chambers R, Stoliker D, Simonsson O (2023) Psychedelic-assisted psychotherapy and mindfulness-based cognitive therapy: potential synergies. Mindfulness. 14:2111\u20132123. https:\/\/doi.org\/10.1007\/s12671-023-02206-4","journal-title":"Mindfulness."},{"issue":"6","key":"2188_CR61","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s43440-023-00551-8","volume":"75","author":"P Holas","year":"2023","unstructured":"Holas P, Kami\u0144ska J (2023) Mindfulness meditation and psychedelics: potential synergies and commonalities. Pharmacol Rep 75(6):1398\u20131409. https:\/\/doi.org\/10.1007\/s43440-023-00551-8","journal-title":"Pharmacol Rep"},{"issue":"2","key":"2188_CR62","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/acsptsci.1c00034","volume":"4","author":"JE Payne","year":"2021","unstructured":"Payne JE, Chambers R, Liknaitzky P (2021) Combining psychedelic and mindfulness interventions: synergies to inform clinical practice. ACS Pharmacol Transl Sci 4(2):416\u2013423. https:\/\/doi.org\/10.1021\/acsptsci.1c00034","journal-title":"ACS Pharmacol Transl Sci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02188-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:02:46Z","timestamp":1780538566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02188-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02188-5","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was con ducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Ethical approval Not applicable. The study was a systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. The study was a systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}